Page 7 - Thinprep System News Today

Barclays PLC cut its stake in Hologic, Inc. (NASDAQ:HOLX – Free Report) by 27.0% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 425,134 shares of the medical equipment provider’s stock after selling 157,628 shares during the period. Barclays PLC owned about […]

Hologic (NASDAQ:HOLX – Get Free Report) issued its earnings results on Thursday. The medical equipment provider reported $0.98 EPS for the quarter, topping the consensus estimate of $0.95 by $0.03, Briefing.com reports. The business had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $989.32 million. Hologic had a return on […]

Qsemble Capital Management LP bought a new position in Hologic, Inc. (NASDAQ:HOLX – Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 16,600 shares of the medical equipment provider’s stock, valued at approximately $1,152,000. A number of other hedge funds have also […]

Hologic (NASDAQ:HOLX – Get Free Report) had its target price upped by equities researchers at Raymond James from $85.00 to $88.00 in a research note issued to investors on Friday, Benzinga reports. The firm presently has an “outperform” rating on the medical equipment provider’s stock. Raymond James’ price objective suggests a potential upside of 20.86% […]

Hologic (NASDAQ:HOLX – Get Free Report) updated its second quarter earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $0.95 to $1.00 for the period, compared to the consensus estimate of $0.98. The company issued revenue guidance of $990 million to $1.010 billion, compared to the consensus revenue estimate of $994.39 […]

Hologic (NASDAQ:HOLX – Get Free Report) issued an update on its second quarter 2024 earnings guidance on Thursday morning. The company provided earnings per share guidance of 0.950-1.000 for the period, compared to the consensus earnings per share estimate of 0.980. The company issued revenue guidance of $990.0 million-$1.0 billion, compared to the consensus revenue […]

Hologic, Inc. (NASDAQ:HOLX – Get Free Report) CFO Karleen Marie Oberton sold 14,940 shares of the company’s stock in a transaction that occurred on Monday, January 29th. The stock was sold at an average price of $75.00, for a total value of $1,120,500.00. Following the completion of the sale, the chief financial officer now owns […]

Hologic (NASDAQ:HOLX – Get Free Report) issued an update on its second quarter 2024 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 0.950-1.000 for the period, compared to the consensus estimate of 0.980. The company issued revenue guidance of $990.0 million-$1.0 billion, compared to the consensus revenue estimate of […]

Hologic (NASDAQ:HOLX – Get Free Report) announced its quarterly earnings data on Thursday. The medical equipment provider reported $0.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.95 by $0.03, Briefing.com reports. Hologic had a return on equity of 19.12% and a net margin of 11.31%. The firm had revenue of […]

Hologic (NASDAQ:HOLX – Free Report) had its price objective upped by Raymond James from $85.00 to $88.00 in a research note published on Friday morning, Benzinga reports. They currently have an outperform rating on the medical equipment provider’s stock. Several other research firms also recently issued reports on HOLX. Needham & Company LLC lifted their […]